Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1

JN Nkengasong, M Peeters, P Nys, B Willems, P Piot, G van der Groen

Research output: Contribution to journalA1: Web of Science-articlepeer-review

Abstract

The relationship was investigated between a viral infectious titer in peripheral blood mononu-clear cells (PBMC) and plasma on the replicative and syncytium-inducing capacity of human immunodeficiency virus type 1 (HIV-1) isolates. The replicative capacity was defined as the minimum time required for p24 antigen to become positive in PBMCs or plasma of HIV-1 infected individuals, cocultured with PBMCs of healthy donors. Syncytium induction was determined by the MT-2 cell assay and defined as the presence of giant multinucleated cells. The replicative capacity of HIV-1 in PBMCs of healthy donors correlated with the infectious viral titer in PBMCs, but not in the plasma of HIV-1 positive patients. Syn-cytia formation in MT-2 cells was not related to the infectious viral titer in PBMCs or plasma of HIV-1 positive patients. These findings suggest that syncytium formation, not replicative capacity, is an intrinsic HIV-1 phenotype. © 1995 Wiley-Liss, Inc.
Original languageEnglish
JournalJournal of Medical Virology
Volume45
Issue number1
Pages (from-to)78-81
Number of pages4
ISSN0146-6615
DOIs
Publication statusPublished - 1995

Keywords

  • B780-tropical-medicine
  • Viral diseases
  • HIV-1
  • Pathogenicity

Fingerprint

Dive into the research topics of 'Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1'. Together they form a unique fingerprint.

Cite this